Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Research Article Volume 4 Issue 1

To Compare Efficacy of Nishkatakadi Kwath with Metformin in Madhumeha with Special Reference to Diabetes Mellitus II

Yashashree B Kulkarni1, Bhairav B Tawshikar2*, Dipali Amale2 and Shrikant G Deshmukh4

1PG Scholar, Rognidan Department, CSMSS, Ayurved College, Aurangabad, India
2Associate Professor, Kayachikitsa Department ARAC Ayurved College, Manchihill, Sangamner, India
3Professor and HOD, Rognidan Department CSMSS Ayurved College, Aurangabad, India
4Professor and HOD, Kaychikitsa Department, CSMSS Ayurved College, Aurangabad, India

*Corresponding Author: Bhairav B Tawshikar, Associate Professor, Kayachikitsa Department ARAC Ayurved College, Manchihill, Sangamner, India.

Received: December 13, 2019; Published: December 31, 2019

×

Abstract

  Madhumeha is a disease known since ancient times to the mankind, its upsurge is quiet alarming. On the basis of its symptomatology Madhumeha can be correlated to the features of Diabetes mellitus.
  Diabetes mellitus is a metabolic disorder of carbohydrate, fat, and protein characterized by hyperglycemia with or without glycosuria. It is associated with long-term potentially catastrophic effects on almost all systems of the body.
  Ayurveda can provide better management for Madhumeha without hazardous side effects. In Ayurveda, Madhumeha has been described as one among one of the 20 types of Prameha and is a sub-type of Vatika Prameha. In the former type the patients are usually asthenic can be correlated with Type I DM and in the latter type patients are obese and can be equated with Type II DM. Nishakatakadi Kwath has been mentioned in Sahasrayoga under Kashaya Prakaran for Prameha Chikitsa, Nishakatakadi Kwath is being used widely for the treatment of Madhumeha in Kerala. That is why Nishakatakadi Kwath has been selected for the present study.
  In this study to study various clinical symptoms of madhumeha with special reference to Diabetes Mellitus II. To compare efficacy of Nishkatakadi Kwath with Metformin in the management of Madhumeha, to observe any possible adverse effect of Nishkatakadi kwath if reported during the study. In the present study Trial and Control groups comprising 30 patients each of Madhumeha (Diabetes Mellitus type II) were treated with Nishkatakadi kwath with tab metformin and Tab Metformin alone respectively. This study shows that both the drugs NISHKATAKADI KWATH with metformin are more effective than METFORMIN in Madhumeha to reduce symptoms and patients score.

Keywords: Madhumeha; Nishkatkadi Kwath; Diabetic Mellitus

×

References

  1. Charak Samhita Chikitsa Sthan 6/1,Prof. Ravidatta Tripathi, Chaukhamba Sanskrit Sansthan, Varanasi, Reprint (2002).
  2. Prameha Adhyay, Sahasrayogam, Chaukhamba Sanskrit Sansthan, Banaras Ayurveda Series 18, Dr. K. Nitheshwar.
  3. Scheen AJ and Paquot N. “Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes”. Diabetes and Metabolism 39 (2013): 179-190.
  4. Wickenberg J., et al. “Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects”. Nutrition Journal 9 (2010): 43.
×

Citation

Citation: Bhairav B Tawshikar., et al. “To Compare Efficacy of Nishkatakadi Kwath with Metformin in Madhumeha with Special Reference to Diabetes Mellitus II". Acta Scientific Nutritional Health 4.1 (2020): 171-177.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.316

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US